Abstract:Background: Osteogenesis imperfecta (OI), also known as brittle bone disease, is a rare heterogeneous group of inherited disorders characterized by low bone mass and increased bone fragility. The four major clinical criteria for diagnosis of OI are osteoporosis with abnormal fragility of the skeleton, blue sclera, dentinogenesis imperfecta, and premature otosclerosis. The presence of two of these abnormalities confirms the diagnosis. More than 90% patients have autosomal dominant mutations in one of the two genes, COL1A1 and COL1A2, that encode the alpha chains of type I collagen. While the diagnosis of OI is still based on clinical and radiological grounds, there is a growing demand for the molecular characterization of causative mutations. Although there have been several studies on the mutational spectra of COL1A1 and/or COL1A2 in Western populations, very few cases have been reported from Asia. The purpose of this study is to report two patients with OI type I in a Chinese family, who had a novel RNA-splicing mutation in COL1A1 gene and describe the molecular, radiological and clinical findings. Methods: The proband, (case II-5), a 32-y-old Chinese male, and his 7-y-old daughter were diagnosed as OI type I according to their clinical and radiological features. Genomic DNA was extracted from their blood samples and all promoters, exons and exon/intron boundaries of COL1A1 and COL1A2 genes were sequenced. Polymerase chain reaction sequence-specific primers (PCR-SSP) was used to confirm patients' heterozygous state. Results: Direct DNA sequencing analysis of COL1A1 gene revealed a splicing mutation (c.1875+1G>A, also as IVS 27+1G>A) that converted the 5' end of intron 27 from GT to AT. This mutation was found in both 2 affected individuals but 9 unaffected relatives and the 50 controls were not observed, which was consistent with the clinical diagnosis. This mutation (c.1875+1G>A) appeared to be novel, which is neither reported in literature nor registered in the Database of Collagen Mutations. The heterozygous states of patients' intron 27 were confirmed by PCR-SSP. Conclusion: We identify a novel RNA-splicing mutation (c.1875+1G>A) in COL1A1 gene resulting in OI type I in a Chinese family. The detailed molecular and clinical features will be useful for extending the evidence for genetic and phenotypic heterogeneity in OI and exploring the phenotype-genotype correlations in OI.

Genotype and Phenotype Analysis of Taiwanese Patients with Osteogenesis Imperfecta

Clinical and genetic analysis in 185 Chinese probands of osteogenesis imperfecta

Clinical Features of Osteogenesis Imperfecta in Taiwan

Genotype-Phenotype Association Analysis Reveals New Pathogenic Factors for Osteogenesis Imperfecta Disease.

Genotype and Phenotype Correlation of Patients with Osteogenesis Imperfecta

Genotype-Phenotype Relationship and Follow-up Analysis of a Chinese Cohort with Osteogenesis Imperfecta

Genotype–phenotype relationship and comparison between eastern and western patients with osteogenesis imperfecta

Genotype-phenotype correlations in 294 pediatric patients with osteogenesis imperfecta

Phenotype and Genotype Analysis of Chinese Patients with Osteogenesis Imperfecta Type V.

Mutation Detection of COL1A1 Gene in a Pedigree with Osteogenesis Imperfecta

Mutations in COL1A1 of Type I Collagen Genes in Chinese Patients with Osteogenesis Imperfecta

Advance of Genetic Studies on Osteogenesis Imperfecta

Identification and Molecular Characterization of Two Novel Mutations in COL1A2 in Two Chinese Families with Osteogenesis Imperfecta

NOVEL MUTATIONS IN THE WNT1, TMEM38B, P4HB, AND PLS3 GENES IN FOUR UNRELATED CHINESE FAMILIES WITH OSTEOGENESIS IMPERFECTA.

Genotypic and Phenotypic Analysis in Chinese Cohort With Autosomal Recessive Osteogenesis Imperfecta

Application of Next-Generation Sequencing for Molecular Diagnosis in a Large Family with Osteogenesis Imperfecta Type I

Genotypic And Phenotypic Characteristics Of 29 Patients With Rare Types Of Osteogenesis Imperfecta: Average 5 Years Of Follow-Up

A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family

Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta

A novel collagen,type Ⅰ,alpha Ⅰ mutation in a Chinese osteogenesis imperfecta family

Mutation Analysis of COL1A1 and COL1A2 in Fetuses with Osteogenesis Imperfecta Type II/III